DDD Partners LLC Grows Holdings in Intuitive Surgical, Inc. $ISRG

DDD Partners LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 746.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 5,504 shares of the medical equipment provider’s stock after acquiring an additional 4,854 shares during the quarter. DDD Partners LLC’s holdings in Intuitive Surgical were worth $2,462,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Brighton Jones LLC raised its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC increased its stake in shares of Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the last quarter. Bayforest Capital Ltd acquired a new stake in Intuitive Surgical in the second quarter valued at $199,000. Harbour Investments Inc. boosted its stake in Intuitive Surgical by 95.5% during the 2nd quarter. Harbour Investments Inc. now owns 2,976 shares of the medical equipment provider’s stock valued at $1,617,000 after acquiring an additional 1,454 shares during the last quarter. Finally, Mutual Advisors LLC boosted its stake in Intuitive Surgical by 5.7% during the 2nd quarter. Mutual Advisors LLC now owns 1,605 shares of the medical equipment provider’s stock valued at $796,000 after acquiring an additional 86 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the sale, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 56,189 shares of company stock worth $30,785,441. 0.70% of the stock is owned by insiders.

Intuitive Surgical Trading Up 1.5%

NASDAQ:ISRG opened at $485.84 on Friday. The stock has a 50 day moving average of $541.62 and a 200-day moving average of $510.24. The firm has a market capitalization of $172.54 billion, a PE ratio of 61.58, a price-to-earnings-growth ratio of 3.71 and a beta of 1.65. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. BTIG Research reissued a “buy” rating and issued a $616.00 target price on shares of Intuitive Surgical in a research report on Friday, January 23rd. Rothschild & Co Redburn upped their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, January 21st. The Goldman Sachs Group reiterated a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. Finally, TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $617.23.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.